ARTELO BIOSCIENCES, INC. Other Nonoperating Income (Expense)
ARTELO BIOSCIENCES, INC. (ARTL) reported Other Nonoperating Income (Expense) of $1.62 thousand for the 3-month period ending 2021-05-31, per its 10-Q filed 2021-07-12.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2021-07-12
- ARTELO BIOSCIENCES, INC. other nonoperating income (expense) for the quarter ending 2021-05-31 was $1.62K, a 694.12% increase year-over-year.
- ARTELO BIOSCIENCES, INC. other nonoperating income (expense) for the quarter ending 2021-02-28 was $1.59K, a 289.22% increase year-over-year.
- ARTELO BIOSCIENCES, INC. other nonoperating income (expense) for the quarter ending 2020-11-30 was $567.00, a 98.12% decline year-over-year.
- ARTELO BIOSCIENCES, INC. other nonoperating income (expense) for the quarter ending 2020-05-31 was $204.00, a 99.97% decline year-over-year.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month |
|---|---|---|---|
| 2021-05-31 | $1.62K 10-Q · filed 2021-07-12 | $3.21K derived: sum of 2 quarters · filed 2021-07-12 | $3.77K 10-Q · filed 2021-07-12 |
| 2021-02-28 | $1.59K 10-Q · filed 2021-04-13 | $2.15K 10-Q · filed 2021-04-13 | |
| 2020-11-30 | $567.00 10-Q · filed 2021-01-14 | ||
| 2020-05-31 | $204.00 10-Q · filed 2021-07-12 | $612.00 derived: sum of 2 quarters · filed 2021-07-12 | $30.70K 10-Q · filed 2021-07-12 |
| 2020-02-29 | $408.00 10-Q · filed 2021-04-13 | $30.50K 10-Q · filed 2021-04-13 | |
| 2019-11-30 | $30.09K 10-Q · filed 2021-01-14 | ||
| 2019-05-31 | $596.40K 10-Q · filed 2020-07-13 | $929.53K derived: sum of 2 quarters · filed 2020-07-13 | $929.53K 10-Q · filed 2020-07-13 |
| 2019-02-28 | $333.13K 10-Q · filed 2020-04-13 | $333.13K 10-Q · filed 2020-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |